Creating personalized plans to treat disease may be possible based not only on the mutant genes causing a disease,, but also other genes in the patient's genome.
Genotyping cancer cells and understanding what genes are dysregulated allows physicians to select the best chemotherapy and potentially expose the patient to less toxic treatment since the therapy is tailored.